Global Infertility Treatment Devices & Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In 2021, Hamilton Thorne Ltd. received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.

• In 2020, Genea Biomedx (Australia) collaborated with Hamilton Thorne to commercialize Genea Biomedx’s (Australia) fertility products in the US and Canada.

The Global Infertility Treatment Devices & Equipment Market has been segmented by Type, Product Type, Procedure, and End-Use, each of which highlights different aspects of the market and helps understand its dynamics.

In terms of Type, the market is primarily segmented into Male Infertility Treatment Devices and Female Infertility Treatment Devices. Male infertility treatments include devices such as sperm processing units, vibrators for sperm retrieval, and devices for semen analysis. Female infertility treatments encompass a broader range of devices, including ovulation stimulators, intrauterine insemination (IUI) devices, and ovarian stimulation devices, as well as more complex equipment like IVF (in vitro fertilization) machines. The growing demand for these devices is driven by increasing rates of infertility in both men and women globally, with lifestyle changes, delayed marriages, and environmental factors contributing to these rising trends.

Product Type segmentation includes various tools designed to assist in the diagnosis and treatment of infertility. Products like IVF Equipment, which includes incubators, culture media, and embryo transfer catheters, are critical for assisted reproductive technologies (ART). Other types of products include Semen Analysis Devices, Sperm Processing Equipment, Ovulation Monitors, and IUI Catheters. IVF equipment holds a significant share of the market, as the rise in IVF treatments, fueled by a growing awareness of assisted reproductive technologies and increasing fertility issues, drives demand. Products like ovulation monitors and semen analysis devices also see strong demand, particularly as couples seek earlier diagnosis and treatment.

The Procedure segmentation focuses on the specific infertility treatments being performed, which include In-Vitro Fertilization (IVF), Artificial Insemination (AI), IUI, and Surrogacy. IVF, which involves the fertilization of eggs outside the body, is one of the most widely performed and most complex procedures, leading to higher demand for specialized devices and equipment. IUI and AI are less invasive procedures that also use devices like catheters and sperm processing equipment, contributing to their widespread use. Surrogacy, while less common, has specific device requirements for egg retrieval, embryo implantation, and monitoring, further adding to market growth.

In terms of End-Use, the primary segments are Hospitals, Fertility Clinics, and Homecare Settings. Fertility clinics represent the largest share of the market, as they offer specialized care and a range of infertility treatments, including IVF and IUI, with the necessary equipment on-site. Hospitals also play a significant role, particularly in the more complex and high-risk fertility treatments. Homecare settings are emerging as a growing segment, driven by the increasing availability of ovulation monitors, at-home sperm tests, and other diagnostic devices that allow individuals to manage fertility treatments at home. As patients look for more personalized and convenient options, this segment is expected to experience growth in the coming years.

Each of these segments reflects the diverse needs of individuals seeking fertility treatments, from basic diagnostics to advanced ART procedures, ensuring that the market for infertility treatment devices and equipment continues to expand.

Global Infertility Treatment Devices & Equipment Market Analysis

In this report, the Global Infertility Treatment Devices & Equipment Market has been segmented by Type, Product Type, Procedure, End Use, and Geography.

Global Infertility Treatment Devices & Equipment Market , Segmentation by Type

The Global Infertility Treatment Devices & Equipment Market has been segmented by Type into Female Infertility Treatment and Male Infertility Treatment.

Female infertility treatment encompasses a wide range of interventions aimed at addressing various underlying causes of infertility, such as ovulatory dysfunction, tubal factors, endometriosis, and uterine abnormalities. Treatment modalities for female infertility include ovulation induction medications, intrauterine insemination (IUI), in vitro fertilization (IVF), and surgical procedures such as laparoscopy and hysteroscopy. Assisted reproductive technology (ART) procedures, such as IVF and intracytoplasmic sperm injection (ICSI), are particularly effective for overcoming female infertility factors, offering alternative pathways to conception for women with compromised reproductive function. With advancements in ART techniques, including preimplantation genetic testing and embryo selection technologies, the success rates of female infertility treatments continue to improve, driving market growth in this segment.

Male infertility treatment focuses on addressing factors that affect sperm production, sperm quality, or sperm transport, leading to difficulties in achieving pregnancy. Treatment modalities for male infertility include lifestyle modifications, hormonal therapy, surgical interventions, and assisted reproductive technologies such as intrauterine insemination (IUI) and in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). Diagnostic tests such as semen analysis, sperm DNA fragmentation testing, and sperm function assays are essential for assessing male fertility status and guiding treatment decisions. Additionally, advancements in reproductive medicine, such as sperm retrieval techniques and sperm selection methods, offer new possibilities for overcoming male infertility challenges. With increasing awareness about male infertility and growing acceptance of male-focused treatments, the market for male infertility treatment devices and equipment is experiencing steady growth, supported by factors such as rising infertility prevalence, changing societal norms, and expanding treatment options.

Global Infertility Treatment Devices & Equipment Market , Segmentation by Product Type

The Global Infertility Treatment Devices & Equipment Market has been segmented by Product Type into Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, and Others.

Ovum Aspiration Pumps are used to retrieve eggs from the ovaries during the IVF process. These devices are integral to the success of IVF, as they help facilitate the collection of mature eggs for fertilization. The demand for ovum aspiration pumps is directly correlated with the increasing prevalence of IVF treatments. As IVF becomes a more common solution to infertility, particularly in developed countries, the need for efficient and accurate egg retrieval processes drives the market for these devices. Technological advancements that improve precision, comfort, and success rates contribute to the growing adoption of ovum aspiration pumps.

Sperm Separation Devices are used in ART procedures to isolate viable sperm from semen, which is essential for both artificial insemination (AI) and IVF. These devices ensure that only the highest-quality sperm are used in fertilization, increasing the chances of successful pregnancy. With the rising number of male infertility cases, there has been a growing demand for sperm separation devices. These devices are particularly valuable in cases where semen analysis and processing are required for IVF and IUI (intrauterine insemination), driving their market growth.

Sperm Analyzer Systems are critical for assessing sperm quality by evaluating various parameters, such as motility, concentration, and morphology. These systems are used in fertility clinics and hospitals to diagnose male infertility and optimize sperm quality for ART procedures. The increasing awareness of male infertility issues and the rising demand for early-stage diagnosis are propelling the adoption of sperm analyzers. As more men seek fertility treatments, particularly in regions where delayed childbearing is becoming more common, the market for sperm analyzer systems is expected to grow.

Micromanipulator Systems are used during the IVF process for sperm injection into eggs (ICSI – intracytoplasmic sperm injection). These systems allow for precise manipulation of eggs and sperm, enhancing the success rate of fertilization. With advancements in micromanipulation technologies, such as the ability to handle oocytes (egg cells) and sperm with greater precision, micromanipulators have become essential tools in IVF clinics, especially in cases of severe male infertility. This contributes to the increasing adoption of these systems.

Incubators are essential in maintaining optimal conditions for the development of embryos in IVF procedures. These devices simulate the conditions of the human womb, providing the necessary environment for embryo growth and development after fertilization. As the demand for IVF treatments continues to rise, so does the need for advanced incubators, which help ensure higher success rates by providing a stable and controlled environment for embryo culture. Incubators are seeing continued improvements, such as the introduction of time-lapse technology, which monitors embryo development in real time, further enhancing their importance in fertility treatments.

Finally, the Others category includes a wide range of devices that play a supporting role in infertility treatments, such as cryopreservation equipment for storing eggs, sperm, and embryos, as well as various diagnostic and monitoring tools. While individually these devices may not hold as large a market share as the aforementioned product types, their collective contribution to the infertility treatment ecosystem is significant.

Together, these product types reflect the complexity of infertility treatments, where precise diagnostic tools, specialized equipment, and supportive technologies all contribute to the overall success of ART procedures. The growing prevalence of infertility and the increasing reliance on ART are key drivers of market expansion for each of these devices.

Global Infertility Treatment Devices & Equipment Market , Segmentation by Procedure

The Global Infertility Treatment Devices & Equipment Market has been segmented by Procedure into Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgery.

Assisted Reproductive Technology (ART) encompasses a range of advanced procedures, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo transfer. ART has revolutionized the field of infertility treatment, providing solutions for both male and female infertility. ART procedures typically require a variety of specialized devices, such as incubators, micromanipulators, sperm analyzers, and ovum aspiration pumps. The increasing adoption of ART, driven by rising infertility rates, delayed childbirth, and advances in medical technology, is significantly contributing to the market growth of ART devices. As ART procedures continue to gain popularity and become more accessible, especially in developed economies, the demand for related equipment is expected to rise, making ART the largest procedure segment within the infertility treatment devices market.

Artificial Insemination (AI) is a simpler, less invasive infertility treatment compared to ART. It involves the direct introduction of sperm into a woman’s reproductive system, typically through intrauterine insemination (IUI). AI requires fewer complex devices than ART but still necessitates equipment such as sperm separation devices, syringes, and insemination catheters. While AI is often used for cases of mild male infertility or unexplained infertility, it has seen increasing adoption as a first-line treatment option. The growing demand for minimally invasive fertility treatments, along with increasing awareness of AI as an effective method, contributes to its market expansion. As a result, this segment is witnessing steady growth in demand for devices and equipment, especially in regions where healthcare accessibility is improving.

Fertility Surgery involves surgical interventions to correct physical issues affecting fertility, such as blocked fallopian tubes, endometriosis, or uterine fibroids. Surgical procedures may include laparoscopy, hysteroscopy, and tubal surgery, requiring specialized instruments, including surgical tools, microscopes, and laser systems. Although fertility surgery is less common than ART or AI, it is essential for certain cases, particularly where there is a clear physical obstruction or abnormality causing infertility. The segment’s growth is driven by advancements in minimally invasive surgical techniques and the rising number of patients seeking fertility preservation options. As the success rates of fertility surgeries improve, more patients are opting for surgical solutions, thereby fueling demand for the necessary equipment.

Each of these procedures plays a distinct role in the infertility treatment landscape, with ART being the most widely used and growing the fastest, followed by AI and fertility surgery. The segment growth is influenced by factors such as patient preferences, the availability of advanced technologies, and the rising global demand for fertility treatments. As awareness of infertility treatment options increases and the success rates of these procedures improve, the market for related devices and equipment is expected to expand across all procedure segments.

Global Infertility Treatment Devices & Equipment Market , Segmentation by End Use

The Global Infertility Treatment Devices & Equipment Market has been segmented by End Use into Fertility Clinics, Hospitals & Healthcare Facilities, and Clinical Research Institutes.

Fertility clinics represent a significant segment within the market, serving as specialized centers dedicated to diagnosing and treating infertility in both men and women. These clinics offer a comprehensive range of services, including diagnostic testing, fertility counseling, assisted reproductive technology (ART) procedures, and surgical interventions. With a focus on personalized care and patient-centered approach, fertility clinics play a pivotal role in helping couples navigate the complexities of infertility and explore treatment options tailored to their specific needs and preferences. As the demand for infertility treatments continues to rise, fueled by factors such as changing societal norms, delaying parenthood, and increasing infertility prevalence, fertility clinics are witnessing steady growth, supported by investments in advanced technologies, skilled personnel, and patient-centric services.

Hospitals and other healthcare facilities also play a significant role in providing infertility care, offering a range of diagnostic and treatment services to individuals seeking assistance with fertility issues. These facilities may include obstetrics and gynecology departments, reproductive endocrinology clinics, and specialized infertility centers within hospital settings. Hospitals provide essential infrastructure, expertise, and resources for diagnosing and managing infertility-related conditions, including medical and surgical treatments, assisted reproductive technologies, and fertility preservation services. Additionally, hospitals serve as referral centers for complex cases and provide interdisciplinary care involving reproductive endocrinologists, urologists, genetic counselors, and other specialists. With increasing recognition of infertility as a medical condition and the integration of infertility services into mainstream healthcare, hospitals are expanding their infertility treatment offerings and enhancing collaboration with fertility specialists and allied healthcare professionals to meet the growing demand for infertility care.

Clinical research institutes play a vital role in advancing the field of reproductive medicine through scientific inquiry, translational research, and innovation in infertility treatment technologies. These institutes conduct clinical trials, epidemiological studies, and basic science research aimed at elucidating the underlying causes of infertility, developing new treatment modalities, and improving the outcomes of existing therapies. Clinical research institutes collaborate with academia, industry partners, and healthcare providers to address critical questions in reproductive biology and infertility management, contributing to the evidence base for best practices in infertility care. By conducting cutting-edge research and fostering interdisciplinary collaboration, clinical research institutes drive advancements in infertility treatment devices and equipment, paving the way for novel diagnostic tools, therapeutic interventions, and personalized approaches to infertility care. As the global demand for infertility treatments continues to grow and the pace of scientific discovery accelerates, clinical research institutes play a pivotal role in shaping the future of reproductive medicine and improving outcomes for individuals and couples struggling with infertility.

Global Infertility Treatment Devices & Equipment Market, Segmentation by Geography

In this report, the Global Infertility Treatment Devices & Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Infertility Treatment Devices & Equipment Market Share (%), by Geographical Region, 2024

North America and Europe emerge as leading markets for infertility treatment devices and equipment, driven by advanced healthcare infrastructure, high adoption rates of assisted reproductive technology (ART) procedures, and increasing prevalence of infertility. The United States and major European countries, such as the United Kingdom, Germany, and France, dominate the market, supported by robust regulatory frameworks, reimbursement policies, and investments in infertility research and development. With a growing emphasis on fertility preservation, personalized medicine, and patient-centered care, North America and Europe are witnessing steady market growth, fueled by factors such as rising infertility prevalence, expanding treatment options, and evolving societal norms.

The Asia Pacific region presents significant growth opportunities for the infertility treatment devices and equipment market, driven by factors such as increasing healthcare expenditure, rising awareness about infertility treatment options, and improving accessibility to reproductive healthcare services. Countries such as China, India, and Japan are witnessing growing demand for infertility treatments, fueled by changing lifestyles, delayed parenthood, and increasing infertility prevalence associated with factors such as urbanization, pollution, and stress. Additionally, advancements in healthcare infrastructure, expansion of fertility clinics, and adoption of ART procedures contribute to market growth in the Asia Pacific region. With a large population base and rising disposable incomes, Asia Pacific represents a lucrative market for infertility treatment devices and equipment, attracting investments from key market players and fostering innovation in reproductive medicine.

Latin America and the Middle East and Africa also present growth opportunities for the infertility treatment devices and equipment market, albeit with unique challenges and market dynamics. In Latin America, countries such as Brazil, Mexico, and Argentina are witnessing increasing demand for infertility treatments, driven by factors such as changing demographics, rising infertility prevalence, and expanding access to healthcare services. Despite economic challenges and healthcare disparities, Latin America offers growth potential for market players, supported by efforts to improve healthcare infrastructure, enhance regulatory frameworks, and address unmet medical needs. Similarly, in the Middle East and Africa, countries such as the United Arab Emirates, South Africa, and Saudi Arabia are investing in healthcare infrastructure and expanding infertility treatment options, driven by factors such as increasing healthcare expenditure, changing societal norms, and rising awareness about infertility. With a growing emphasis on reproductive health and family planning, the Middle East and Africa offer opportunities for market expansion and investment in infertility treatment devices and equipment, contributing to improved access to infertility care and patient outcomes. Overall, the geographic segmentation of the infertility treatment market underscores regional disparities in healthcare access and highlights opportunities for market growth and investment across different regions during the forecast period.

This report provides an in depth analysis of various factors that impact the dynamics of Global Infertility Treatment Devices & Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Advancements in Assisted Reproductive Technologies (ART)
• Growing Adoption of Minimally Invasive Procedures
• Rising Awareness and Acceptance of Infertility Treatments

• Expansion of Fertility Tourism - The expansion of fertility tourism represents a significant opportunity for the global infertility treatment devices and equipment market. Fertility tourism, also known as reproductive tourism or cross-border reproductive care, involves individuals traveling to other countries to seek fertility treatments that may be more affordable, accessible, or legally permissible than in their home countries. This trend has gained momentum due to disparities in healthcare costs, regulatory frameworks, and cultural attitudes towards assisted reproductive technologies (ART) across different regions. As a result, fertility clinics and healthcare facilities in popular destination countries are experiencing increased demand for infertility treatments, driving growth in the market for treatment devices and equipment.

  Fertility tourism fosters cross-border collaborations and partnerships among healthcare providers, fertility clinics, and medical tourism agencies, facilitating the exchange of expertise, resources, and best practices in infertility treatment. Clinics in destination countries often invest in state-of-the-art equipment and facilities to attract international patients seeking high-quality care at competitive prices. This investment in infrastructure and technology benefits the infertility treatment market by stimulating demand for advanced treatment devices and equipment, such as in vitro fertilization (IVF) incubators, micromanipulation systems, and embryo transfer catheters.

  The expansion of fertility tourism underscores the globalization of infertility treatment services and the increasing accessibility of ART to individuals worldwide. Advances in transportation and communication technology have made it easier for patients to research treatment options, compare costs, and connect with healthcare providers across borders. Fertility clinics in destination countries leverage digital marketing strategies and online platforms to reach international patients and promote their services, driving market expansion. However, challenges such as regulatory compliance, ethical considerations, and language barriers must be addressed to ensure the safe and ethical provision of infertility treatments in the context of fertility tourism.

Restraints

• Stringent Regulatory Requirements
• Limited Insurance Coverage for Infertility Treatments
• Social Stigma Associated with Infertility

• Ethical and Legal Considerations - Ethical and legal considerations play a significant role in shaping the landscape of the infertility treatment devices and equipment market. The use of assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT), raises complex ethical questions related to reproductive autonomy, donor anonymity, and the commodification of human gametes and embryos. Healthcare providers and fertility clinics must navigate a myriad of ethical dilemmas and adhere to established guidelines and regulations governing the practice of infertility treatment to ensure patient safety and uphold ethical standards.

  Ethical and legal considerations extend to emerging technologies and treatment modalities in infertility care, such as preimplantation genetic testing (PGT), mitochondrial replacement therapy (MRT), and genome editing techniques. These innovative approaches raise profound ethical questions related to genetic selection, embryo manipulation, and the potential for unintended consequences. Healthcare providers, policymakers, and bioethicists must engage in ongoing dialogue and debate to address these ethical challenges and develop ethical guidelines and regulatory frameworks that balance scientific progress with societal values and ethical principles.

  Ethical and legal considerations are integral to the practice of infertility treatment and the development of treatment devices and equipment. By upholding ethical standards, adhering to legal requirements, and promoting transparency and accountability in infertility care, stakeholders can ensure that patients receive safe, effective, and ethically sound treatment options that respect their reproductive autonomy and uphold their dignity and rights.

Opportunities

• Development of Innovative Treatment Technologies
• Personalized Medicine Approaches in Fertility Treatment
• Strategic Partnerships and Collaborations

• Focus on Male Infertility and Reproductive Health - The increasing focus on male infertility and reproductive health represents a significant opportunity for the infertility treatment devices and equipment market. Historically, infertility diagnosis and treatment have primarily focused on female factors, with less attention paid to male reproductive health. However, emerging research and clinical evidence highlight the importance of male factors in infertility, with studies suggesting that up to 50% of infertility cases may involve male factors alone or in combination with female factors. As awareness of male infertility grows, there is a growing emphasis on addressing male reproductive health issues and developing targeted treatment strategies.

  The recognition of male infertility as a public health issue underscores the importance of holistic approaches to reproductive healthcare that address both male and female factors. Healthcare providers and fertility clinics are increasingly offering integrated services and multidisciplinary care models that encompass male infertility evaluation, counseling, and treatment alongside female infertility services. This integrated approach not only improves patient outcomes but also fosters greater inclusivity and equity in infertility care, ensuring that both partners receive comprehensive support and access to appropriate treatment options.

  The focus on male infertility and reproductive health represents a paradigm shift in infertility care, with implications for the development of treatment devices and equipment. By addressing male factors in infertility diagnosis and treatment, stakeholders can improve patient outcomes, enhance reproductive healthcare access, and advance the development of innovative solutions that meet the unique needs of individuals and couples struggling with infertility.

Key players in Global Infertility Treatment Devices & Equipment Market include :

• The Cooper
• Cook
• Vitrolife
• Dxnow
• Eppendorf Ag
• Ab Scientific Lt
• Ivftech Aps
• Rocket Medical

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis